跳转到内容

Lemon Bottle

此内容尚不支持你的语言。

Lemon Bottle presents a product-identity conflict rather than a conventional injectable-product profile. SID MEDICOS states that its authentic Lemon Bottle Ampoule Solution is an external-use cosmetic and is not intended for lipolysis or injection. Swissmedic has separately investigated products carrying the Lemon Bottle name that were offered for injection and classified those presentations as unauthorized medicinal products in Switzerland.

The external-use product and an item sold as Lemon Bottle injection should not be assumed to have the same identity, composition, source, or intended route.

FieldWhat can be established
Named companySID MEDICOS, Republic of Korea
Company position on authentic ampouleCosmetic for external use; not intended for lipolysis or injection
Swiss injectable-product statusClassified as a medicinal product requiring authorization; not authorized for distribution or use in Switzerland
Sample findingSwissmedic did not detect the declared ingredients in samples obtained from different sources
Authenticity boundarySID MEDICOS said it could not verify that the investigated samples were authentic
Core editorial roleProduct authenticity, intended route, and regulatory-classification case

Source: Swissmedic warning of March 26, 2024, with June 25, 2024 addendum 🔗.

Swissmedic reported receiving increasing enquiries about Lemon Bottle products advertised online and through social media for localized fat reduction. Based on the represented composition and injection route, the Swiss cross-agency panel classified the lipolysis solution as a medicinal product.

Because no Swiss medicinal-product authorization existed, Swissmedic stated on March 26, 2024 that the product could not be placed on the Swiss market and should not be sold, dispensed, or used there. The authority also stated that no medicinal effect had been scientifically demonstrated.

This is a jurisdiction-specific legal finding. It supports unauthorized in Switzerland as a medicinal product offered for injection, not a universal statement about every product bearing the name in every country.

Swissmedic tested samples obtained from different sources and reported that it could not detect the ingredients declared for the Lemon Bottle lipolysis solution. This raises at least three separate questions:

  1. whether the tested items were authentic
  2. whether their labeling accurately described their contents
  3. whether any product with that identity was legally authorized for injection

The laboratory result should not be rewritten as proof that every authentic SID MEDICOS cosmetic contains no declared ingredients. The authority’s addendum records that the distributor could not authenticate the investigated samples.

In the June 25, 2024 addendum, Swissmedic records SID MEDICOS’ position that:

  • it could not verify that the samples tested by Swissmedic were original products
  • the original Lemon Bottle Ampoule Solution was exclusively an external-use cosmetic
  • the original product was not intended for lipolysis or injection
  • the packaging and leaflet carried external-use cosmetic wording

That response materially changes how the entity should be indexed. It does not turn injectable use into approved use; it instead separates the manufacturer’s stated cosmetic identity from products promoted or supplied for injection.

The name Lemon Bottle may appear in several contexts:

ContextAppropriate interpretation
SID MEDICOS external-use ampouleCosmetic identity described by the company
Product advertised as fat-dissolving injectionInjectable medicinal purpose requiring market-specific authorization
Unverified online vial or packageIdentity, contents, route, and source unresolved
Lemon Bottle skin-care or skin-booster lineSeparate presentation that should not inherit a lipolysis or injection identity

For this reason, a package photograph, vial color, ingredient list copied from a seller, or the name alone is not enough to identify the product.

In a March 3, 2025 warning letter, FDA told a US seller that its LemonBottle Ampoule Solution and several other products were being marketed with drug claims without approved applications. The letter treated the products’ claimed effects and intended use as drug claims under US law (FDA warning letter to Fox Pharma 🔗).

This describes the US promotion and distribution addressed in the letter. It should not be used to claim that FDA analyzed and authenticated every Lemon Bottle product worldwide.

Composition claims require source attribution

Section titled “Composition claims require source attribution”

Online and promotional materials have associated Lemon Bottle with ingredients such as riboflavin, lecithin, bromelain, and other components. The Swissmedic findings show why such lists cannot be accepted without identifying the exact source and authentic product.

An external-use cosmetic ingredient list also does not establish:

  • sterile manufacture
  • suitability for injection
  • a pharmacologic fat-reduction effect
  • an approved anatomical indication
  • equivalence to a deoxycholic-acid drug or PPC/deoxycholate mixture

Products intended only for external cosmetic use should not be injected. A product offered for injection requires an identifiable authorization, legal manufacturer, sterile presentation, quality controls, labeling, and professional-use framework in the relevant jurisdiction.

If a patient presents after a Lemon Bottle injection, documentation should preserve the exact package, vial, lot, supplier, claimed ingredient list, route, treated area, timing, and remaining product when available. Do not assume that a reaction can be interpreted from the brand name alone.